99-565. Medical Devices; Establishment Registration and Device Listing for Manufacturers and Distributors of Devices; Confirmation of Effective Date  

  • [Federal Register Volume 64, Number 7 (Tuesday, January 12, 1999)]
    [Rules and Regulations]
    [Page 1762]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-565]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 807
    
    [Docket No. 98N-0520]
    
    
    Medical Devices; Establishment Registration and Device Listing 
    for Manufacturers and Distributors of Devices; Confirmation of 
    Effective Date
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Direct final rule; confirmation of effective date.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) published in the 
    Federal Register of September 29, 1998 (63 FR 51825), a direct final 
    rule and a correction document published in the Federal Register of 
    November 27, 1998 (63 FR 65554). The direct final rule amends certain 
    regulations that govern establishment registration and device listing 
    by domestic distributors. This document confirms the effective date of 
    the direct final rule.
    
    EFFECTIVE DATE: The effective date of the direct final rule published 
    at 63 FR 51825 is confirmed as February 11, 1999.
    
    FOR FURTHER INFORMATION CONTACT: Walter W. Morgenstern, Center for 
    Devices and Radiological Health (HFZ-305), Food and Drug 
    Administration, 2094 Gaither Rd., Rockville, MD 20857, 301-594-4699.
    
    SUPPLEMENTARY INFORMATION: FDA solicited comments concerning the direct 
    final rule for a 75-day period ending on December 14, 1998. FDA stated 
    that the effective date of the direct final rule would be on February 
    11, 1999, 60 days after the end of the comment period, unless any 
    significant adverse comment was submitted to FDA during the comment 
    period. FDA did not receive any significant adverse comment. The direct 
    final rule contained no information collection. Therefore, clearance by 
    the Office of Management and Budget under the Paperwork Reduction Act 
    of 1995 (44 U.S.C. 3501-3502) was not required.
        Therefore, under the Federal Food, Drug, and Cosmetic Act, and 
    under authority delegated to the Commissioner of Food and Drugs, notice 
    is given that no objections or requests for a hearing were filed in 
    response to the September 29, 1998, final rule. Accordingly, the 
    amendments issued thereby are effective on February 11, 1999.
    
        Dated: January 4, 1999.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 99-565 Filed 1-11-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
2/11/1999
Published:
01/12/1999
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Direct final rule; confirmation of effective date.
Document Number:
99-565
Dates:
The effective date of the direct final rule published at 63 FR 51825 is confirmed as February 11, 1999.
Pages:
1762-1762 (1 pages)
Docket Numbers:
Docket No. 98N-0520
PDF File:
99-565.pdf
CFR: (1)
21 CFR 807